ACTC Biobank
Accelerating the research behind Alzheimer’s trials
The biorepository of the Alzheimer’s Clinical Trials Consortium.
Sample capacity
11.5M+
Studies supported
20+
Specimens accessioned
50k+
About
What the Biobank is
The ACTC Biobank is a national resource for Alzheimer’s disease research, providing specimen storage, processing, and analysis for clinical trials and longitudinal studies.
Services
From collection to analysis
Specimen Storage
Long-term storage for biospecimens from clinical trials and cohort studies, in monitored −80 °C freezers and liquid nitrogen.
Sample Processing
Receiving, processing and aliquoting of plasma, CSF and other biospecimens, to each study’s collection protocol.
Biomarker Analysis
Single-analyte and multiplex assays on plasma and CSF, run by the biomarker laboratory alongside the repository.
The laboratory
Biomarker discovery for early Alzheimer’s detection
The Biomarker Laboratory works on biomarker discovery in Alzheimer’s disease, with a focus on blood- and CSF-based markers for preclinical detection. Work from the lab has shown that tau and amyloid beta carried in neuronal exosomes can predict conversion from mild cognitive impairment to Alzheimer’s disease — evidence that supports earlier diagnosis and better-targeted trials.
Work with the Biobank
Whether you are requesting specimens for a study or looking to bank specimens from one, the ACTC Biobank is the right place to start. Send us a request to get started.